Weight changes after discontinuing metformin
Pro Research Analysisby 
Searched over 200M research papers
Weight Changes After Discontinuing Metformin: Key Findings
Metformin Discontinuation and Weight Regain in Psychiatric Populations
Several studies have examined the effects of stopping metformin in patients who initially experienced weight loss while on the medication, particularly those taking antipsychotics. In clozapine-treated patients with schizophrenia, metformin significantly reduced body weight and improved metabolic health during treatment. However, after discontinuing metformin, the weight loss benefits disappeared, and mean body weight returned to baseline levels, indicating that the weight reduction was not sustained without ongoing metformin use . Similar findings were observed in patients with first-episode psychosis: metformin helped control antipsychotic-induced weight gain, but this effect did not persist after stopping the drug . These results suggest that metformin’s weight loss benefits in psychiatric populations are largely dependent on continued treatment 13.
Weight Gain After Metformin Discontinuation in Diabetes Management
In patients with diabetes who discontinued metformin—often due to declining renal function—replacement with other antihyperglycemic medications led to significant weight gain. On average, patients gained about 3.8 kg after stopping metformin and switching to alternative therapies. This weight gain was accompanied by a higher risk of hypoglycemia and increased treatment costs, even though blood sugar control was eventually restored with new medications . This highlights that metformin discontinuation can result in notable weight increases, especially when replaced by other diabetes drugs .
Metformin Continuation and Weight Maintenance After Other Drug Withdrawal
A study in obese women with polycystic ovary syndrome (PCOS) who continued metformin after stopping semaglutide (a weight loss medication) found that about one-third of the weight lost during semaglutide treatment was regained over two years. However, most women still maintained a lower body weight compared to their starting point, suggesting that ongoing metformin use may help attenuate, but not completely prevent, weight regain after stopping other weight loss drugs .
Short-Term Metformin Use and Weight Loss in Other Populations
Short-term metformin treatment in people with HIV led to weight loss, but the study did not specifically report on weight changes after discontinuation. More research is needed to determine if the weight loss persists after stopping metformin in this population .
Summary of Evidence
Across different patient groups, the evidence consistently shows that the weight loss and metabolic benefits of metformin are not maintained after discontinuation. Most patients tend to regain the weight they lost while on metformin, especially if no other interventions are in place. Continued metformin use appears necessary to sustain its weight-related benefits, and stopping the medication often leads to weight regain, regardless of the underlying condition being treated 1234.
Conclusion
Metformin is effective for weight loss and metabolic improvement while it is being taken, but these benefits are generally lost after discontinuation. Patients and healthcare providers should be aware that stopping metformin is likely to result in weight regain, and alternative strategies may be needed to maintain weight loss after discontinuation.
Sources and full results
Most relevant research papers on this topic
Provider Decisions and Patient Outcomes After Premature Metformin Discontinuation
Premature metformin discontinuation leads to higher blood glucose levels, weight gain, and increased costs, highlighting the need for expanded metformin recommendations for patients with mild to moderate renal dysfunction.
Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study
Metformin is a safe and tolerable weight control measure for patients with first-episode psychosis, helping them manage their weight better than placebo.
Repurposing Metformin in Nondiabetic People With HIV: Influence on Weight and Gut Microbiota
Metformin treatment for 12 weeks decreased weight and favored anti-inflammatory bacteria abundance in the gut microbiota of nondiabetic HIV-treated individuals with a low CD4/CD8 ratio.
Metformin Discontinuation prior to FDG PET/CT: A Randomized Controlled Study to Compare 24- and 48-hour Bowel Activity.
Metformin discontinuation for 48 hours prior to PET/CT is associated with lower accumulation of fluorodeoxyglucose in the bowel compared to no discontinuation or 24-hour discontinuation.
Effectiveness of Medications Used to Attenuate Antipsychotic-Related Weight Gain and Metabolic Abnormalities: A Systematic Review and Meta-analysis
Metformin is the most effective medication for reducing antipsychotic-induced weight gain, but other treatments show mixed results.
DOI